Trials / Completed
CompletedNCT02901366
Mass Balance Study of FYU-981
Plasma Concentration, Excretion and Mass Balance Orally Administered 14C-FYU-981 in Healthy Male Subjects
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- Fuji Yakuhin Co., Ltd. · Industry
- Sex
- Male
- Age
- 20 Years – 35 Years
- Healthy volunteers
- Accepted
Summary
To assess the plasma pharmacokinetics, the routes extent of elimination, and the metabolites of FYU-981 after a single 1 mg oral dose of 14C-FYU-981 in healthy male subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 14C-FYU-981 | 14C-FYU-981, (Oral single dosing) |
Timeline
- Start date
- 2016-09-01
- Primary completion
- 2017-01-01
- Completion
- 2018-07-01
- First posted
- 2016-09-15
- Last updated
- 2018-08-21
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT02901366. Inclusion in this directory is not an endorsement.